Dose–effect relationship of stereotactic body radiotherapy in non-small cell lung cancer patients
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dose–effect relationship of stereotactic body radiotherapy in non-small cell lung cancer patients
Authors
Keywords
-
Journal
Radiation Oncology
Volume 17, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-12-23
DOI
10.1186/s13014-022-02183-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High-dose stereotactic body radiotherapy using CyberKnife® for stage I peripheral lung cancer: a single-center retrospective study
- (2022) Yasuhiro Ryuno et al. Radiation Oncology
- Relationship between Dose Prescription Methods and Local Control Rate in Stereotactic Body Radiotherapy for Early Stage Non-Small-Cell Lung Cancer: Systematic Review and Meta-Analysis
- (2022) Takahisa Eriguchi et al. Cancers
- Stereotactic body radiotherapy for synchronous early stage non-small cell lung cancer
- (2021) Cole R. Steber et al. ACTA ONCOLOGICA
- Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study
- (2021) Kenta Watanabe et al. Radiation Oncology
- Stereotactic body radiotherapy with a high maximum dose improves local control, cancer-specific death and overall survival in peripheral early-stage non-small cell lung cancer
- (2021) Yudai Tateishi et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery
- (2021) Joe Y Chang et al. LANCET ONCOLOGY
- A Propensity-Matched Analysis of Survival of Clinically Diagnosed Early-Stage Lung Cancer and Biopsy-Proven Early-Stage Non-Small Cell Lung Cancer Following Stereotactic Ablative Radiotherapy
- (2021) Ran Zhang et al. Frontiers in Oncology
- An Analysis of Clinical Toxic Effects and Quality of Life as a Function of Radiation Dose and Volume After Lung Stereotactic Body Radiation Therapy
- (2021) Suneetha Devpura et al. Advances in Radiation Oncology
- Correlating Dose Variables with Local Tumor Control in Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Modeling Study on 1500 Individual Treatments
- (2020) Rainer J. Klement et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer
- (2019) Percy Lee et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non–Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial
- (2019) Andrea Bezjak et al. JOURNAL OF CLINICAL ONCOLOGY
- Long term results of single high dose Stereotactic Body Radiotherapy in the treatment of primary lung tumors
- (2019) Luca Nicosia et al. Scientific Reports
- Surgery and stereotactic body radiotherapy for early-stage non-small cell lung cancer: prospective clinical trials of the past, the present, and the future
- (2019) Masatsugu Hamaji General Thoracic and Cardiovascular Surgery
- Three- Versus Five-Fraction Regimens of Stereotactic Body Radiotherapy for Peripheral Early-Stage Non–Small-Cell Lung Cancer: A Two-Institution Propensity Score–Matched Analysis
- (2018) Sung Jun Ma et al. Clinical Lung Cancer
- Comparing Outcomes of Patients With Early-Stage Non–Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy Based on Frailty Status
- (2018) Govind Raghavan et al. Clinical Lung Cancer
- Comparison of Single- and Five-fraction Regimens of Stereotactic Body Radiation Therapy for Peripheral Early-stage Non–small-cell Lung Cancer: A Two-institution Propensity-matched Analysis
- (2018) Michael A. Cummings et al. Clinical Lung Cancer
- Helical Image-guided Stereotactic Body Radiotherapy (SBRT) for the Treatment of Earlystage Lung Cancer: A Single-institution Experience at the Willis-Knighton Cancer Center
- (2018) Lane R Rosen et al. TUMORI
- Stereotactic body radiotherapy for patients with non-small-cell lung cancer using RapidArc delivery and a steep dose gradient: prescription of 60% isodose line of maximum dose fitting to the planning target volume
- (2018) Yuichiro Tsurugai et al. JOURNAL OF RADIATION RESEARCH
- Correlation of biologically effective dose and the tumor control in Stage I (
- (2017) Wan Jeon et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radiation therapy
- (2016) Narek Shaverdian et al. BRITISH JOURNAL OF RADIOLOGY
- Planning Target Volume D95 and Mean Dose Should Be Considered for Optimal Local Control for Stereotactic Ablative Radiation Therapy
- (2016) Lina Zhao et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months
- (2016) Arturo Navarro-Martin et al. Journal of Thoracic Oncology
- Relationship between the consolidation to maximum tumor diameter ratio and outcomes following stereotactic body radiotherapy for stage I non-small-cell lung cancer
- (2016) Yuichiro Tsurugai et al. LUNG CANCER
- Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy
- (2016) Matthias Guckenberger et al. RADIOTHERAPY AND ONCOLOGY
- Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT – the Nordic experience
- (2015) Karin Lindberg et al. ACTA ONCOLOGICA
- Stereotactic body radiotherapy (SBRT) for the treatment of inoperable stage I non-small cell lung cancer patients
- (2015) L. Ceniceros et al. Clinical & Translational Oncology
- Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403
- (2015) Yasushi Nagata et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Dose–response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance
- (2014) Larry Kestin et al. RADIOTHERAPY AND ONCOLOGY
- Dose–volume–response analysis in stereotactic radiotherapy for early lung cancer
- (2014) Osamu Suzuki et al. RADIOTHERAPY AND ONCOLOGY
- Prognostic factors for local control of stage I non-small cell lung cancer in stereotactic radiotherapy: a retrospective analysis
- (2012) Yuko Shirata et al. Radiation Oncology
- Experience of micromultileaf collimator linear accelerator based single fraction stereotactic radiosurgery: Tumor dose inhomogeneity, conformity, and dose fall off
- (2011) Linda X. Hong et al. MEDICAL PHYSICS
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
- (2010) Robert Timmerman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Outcomes After Stereotactic Lung Radiotherapy or Wedge Resection for Stage I Non–Small-Cell Lung Cancer
- (2010) Inga S. Grills et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size
- (2010) Fumiya Baba et al. Radiation Oncology
- The Role of Stereotactic Body Radiotherapy in the Management of Non-Small Cell Lung Cancer: An Emerging Standard for the Medically Inoperable Patient?
- (2010) Gregory M. M. Videtic et al. Current Oncology Reports
- Stereotactic Body Radiation Therapy for Early-Stage Non–Small-Cell Lung Carcinoma: Four-Year Results of a Prospective Phase II Study
- (2009) Achilles J. Fakiris et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy
- (2009) Pia Baumann et al. JOURNAL OF CLINICAL ONCOLOGY
- Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial
- (2009) Umberto Ricardi et al. LUNG CANCER
- Stereotactic Body Radiotherapy for Primary Lung Cancer at a Dose of 50 Gy Total in Five Fractions to the Periphery of the Planning Target Volume Calculated Using a Superposition Algorithm
- (2008) Atsuya Takeda et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started